Retrovirus vectors

Advances in Experimental Medicine and Biology

Volumn 465, Issue , 2000, Pages 23-35

  Takeuchi, Y ^a   Pizzato, M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CRE RECOMBINASE; GAG PROTEIN; IMMUNOMODULATING AGENT; INTERLEUKIN 2; POL PROTEIN; THYMIDINE KINASE; TUMOR NECROSIS FACTOR ALPHA; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA; VIRUS VECTOR;

CANCER GENETICS; GENE TRANSFER; HUMAN; HUMAN CELL; LENTIVIRINAE; LONG TERMINAL REPEAT; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RNA VIRUS; TRANSGENE; TUMOR ASSOCIATED LEUKOCYTE; VIRUS ENVELOPE; VIRUS GENE; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; GENE THERAPY; GENETIC VECTORS; HUMANS; NEOPLASMS; RETROVIRIDAE;

ALPHAVIRUS; LENTIVIRUS; MIRIDAE; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0034481346     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (95)

1. Internal initiation of translation in retroviral vectors carrying picornavirus 5′ nontranslated regions
2. A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines
3. Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E
4. Retrotransposons, endogenous retroviruses, and the evolution of retroelements
5. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
6. Construction and applications of a highly transmissible routine retrovirus shuttle vector
7. Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy
8. Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system
9. A replication-competent retrovirus arising from a splitfunction packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences
10. Replication-competent retrovirus produced by a "split-function" third generation amphotropic packaging cell line
11. Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the IoxP site
12. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer
13. Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies
14. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins
15. Retroviral vectors, (L.J
16. Lysis of RNA tumor viruses by human serum: Direct antibody-independent triggering of the classical complement pathway
17. Targeting retrovirus entry
18. High-Liter packaging cells producing recombinant retroviruses resistant to human serum
19. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges
20. Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma
21. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism
22. Comparison of promoter suppression in avian and murine retrovirus vectors
23. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus
24. The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell- virus linker
25. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector
26. Cre/IoxP-mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat-driven transcription in human hematopoietic cells
27. A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers
28. kat: A high-efficiency retroviral transduction system for primary human T lymphocytes
29. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos
30. Tight control of gene expression in mammalian cells by tetracyclineresponsive promoters
31. Retroviral Vectors
32. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector
33. Efficient packaging of a specific VL30 retroelement by psi 2 cells which produce MoMLV recombinant retroviruses
34. Retroviral diversity and distribution in vertebrates
35. Virosomes: Cationic liposomes enhance retroviral transduction
36. Apparent recombinants between virus-like (VL30) and murine leukemia virus-related sequences in mouse DNA
37. Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies
38. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters
39. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1
40. Packaging system for rapid production of murine leukemia virus vectors with variable tropism
41. Transient expression of SV 40 large T antigen by Cre/LoxP-mediated site-specific deletion in primary human tumor cells
42. An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: Biological and biochemical characterization
43. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus
44. Construction and use of a safe and efficient amphotropic packaging cell line
45. Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope
46. Development and application of retroviral vectors
47. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production
48. Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry
49. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
50. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
51. A family of retroviruses that utilize related phosphate transporters for cell entry
52. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
53. Masking of retroviral envelope functions by oligomerizing polypeptide adaptors
54. Enhanced transduction efficiency of retroviral vectors coprecipitated with calcium phosphate
55. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
56. Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity
57. Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus
58. The cellular receptor for gibbon ape leukemia virus is a novel high affinity sodium-dependent phosphate transporter
59. Gene transfer vectors derived from equine infectious anemia virus
60. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
61. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells
62. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells
63. Production of high-titer helper-free retroviruses by transient transfection
64. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentMral vectors
65. Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo
66. Replication-competent chimeric lentioncovirus with expanded host cell tropism
67. A novel human amphotropic packaging cell line: High titer, complement resistance, and improved safety
68. Gene therapy for cancer: What have we done and where are we going?
69. A novel mechanism of retrovirus inactivation in human serum mediated by antialpha-galactosyl natural antibody
70. A versatile and potentially general approach to the targeting of specific cell types by retroviruses: Application to the infection of human cells by means of major histocompatibility complex class 1 and class II antigens by mouse ecotropic murine leukemia virus-derived viruses
71. Identification of genes induced by factor deprivation in hematopoietic cells undergoing apoptosis using genetrap mutagenesis and site-specific recombination
72. Self-deleting retrovirus vectors for gene therapy
73. Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors
74. Human cells infected with retrovirus vectors acquire an endogenous murine provirus
75. Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein
76. A transient three-plasmid expression system for the production of high titer retroviral vectors
77. A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes
78. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell
79. Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha 1-3)galactosylation
80. Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase
81. Receptor cooperation in retrovirus entry: Recruitment of an auxiliary entry mechanism after retargeted binding
82. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU
83. A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family
84. Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter
85. Retroviral virions and genomes
86. Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors
87. Pseudotypes of avian sarcoma viruses with the envelope properties of vesicular stomatitis virus
88. Human serum lyses RNA tumour viruses
89. Inactivation of lysis of oncornaviruses by human serum
90. Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination
91. Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors
92. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein
93. A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes
94. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells
95. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo